SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-23-079586
Filing Date
2023-09-26
Accepted
2023-09-26 16:34:25
Documents
25
Period of Report
2023-09-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea185680-8k_oramedpharma.htm   iXBRL 8-K 57548
2 SECURITIES PURCHASE AGREEMENT, DATED SEPTEMBER 21, 2023 BY AND BETWEEN SCILEX HO ea185680ex10-1_oramedpharma.htm EX-10.1 308403
3 SENIOR SECURED PROMISSORY NOTE, DATED SEPTEMBER 21, 2023 ISSUED TO ORAMED PHARMA ea185680ex10-2_oramedpharma.htm EX-10.2 252257
4 WARRANT NO. ORMP CS-1 TO PURCHASE COMMON STOCK OF SCILEX HOLDING COMPANY ea185680ex10-3_oramedpharma.htm EX-10.3 133250
5 WARRANT NO. ORMP CS-2 TO PURCHASE COMMON STOCK OF SCILEX HOLDING COMPANY ea185680ex10-4_oramedpharma.htm EX-10.4 133416
6 WARRANT NO. ORMP CS-3 TO PURCHASE COMMON STOCK OF SCILEX HOLDING COMPANY ea185680ex10-5_oramedpharma.htm EX-10.5 132965
7 WARRANT NO. ORMP CS-4 TO PURCHASE COMMON STOCK OF SCILEX HOLDING COMPANY ea185680ex10-6_oramedpharma.htm EX-10.6 134582
8 WARRANT NO. ORMP CS-5 TO PURCHASE COMMON STOCK OF SCILEX HOLDING COMPANY ea185680ex10-7_oramedpharma.htm EX-10.7 133612
9 SCILEX HOLDING COMPANY SPECIMEN WARRANT CERTIFICATE ea185680ex10-8_oramedpharma.htm EX-10.8 21848
10 REGISTRATION RIGHTS AGREEMENT, DATED SEPTEMBER 21, 2023, BY AND BETWEEN ORAMED P ea185680ex10-9_oramedpharma.htm EX-10.9 143784
11 SUBSIDIARY GUARANTEE, DATED SEPTEMBER 21, 2023, BY AND AMONG ORAMED PHARMACEUTIC ea185680ex10-10_oramedpharma.htm EX-10.10 90330
12 SECURITY AGREEMENT, DATED SEPTEMBER 21, 2023, BY AND AMONG ORAMED PHARMACEUTICAL ea185680ex10-11_oramedpharma.htm EX-10.11 172765
13 MUTUAL TERMINATION AND RELEASE AGREEMENT, DATED SEPTEMBER 21, 2023, BY AND BETWE ea185680ex10-12_oramedpharma.htm EX-10.12 31739
14 PRESS RELEASE, DATED SEPTEMBER 21, 2023 ea185680ex99-1_oramedpharma.htm EX-99.1 18217
  Complete submission text file 0001213900-23-079586.txt   2377176

Data Files

Seq Description Document Type Size
15 XBRL SCHEMA FILE ormp-20230921.xsd EX-101.SCH 3009
16 XBRL LABEL FILE ormp-20230921_lab.xml EX-101.LAB 34240
17 XBRL PRESENTATION FILE ormp-20230921_pre.xml EX-101.PRE 22355
19 EXTRACTED XBRL INSTANCE DOCUMENT ea185680-8k_oramedpharma_htm.xml XML 3320
Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 646-844-1164
ORAMED PHARMACEUTICALS INC. (Filer) CIK: 0001176309 (see all company filings)

IRS No.: 980376008 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35813 | Film No.: 231280853
SIC: 2834 Pharmaceutical Preparations